Clinical Trial Update: Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of TJO-083 in patients with dry eye conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Dry Eye Syndrome

Drugs mentioned

• TJO-083

Snippet

Sponsor: Taejoon Pharmaceutical Co., Ltd. | Conditions: Dry Eye, Dry Eye Syndromes | Phase 3 | Status: COMPLETED